Regen BioPharma Inc (RGBP)

[cvinvestor]

Dmort, the numbers don't add up. How can you dream of preferred shares being valued at $100 in a buyout? That would mean the big 3 just gave themselves bonuses of $1B each for getting HemaX approved for clinical trials. How does that make sense?

Lilly is not "on board". The agreement allows RGBP to submit entries into Lilly's compound research and of course to do so, Lilly in return has the right to buy or license compounds they get interested in. It's a good thing, but it's on parallel with the NIH research agreement. It's not a billion dollar deal.

At the rate preferred shares (the share of choice) are currently going out the door, a buyout of RGBP might get no more the $1-$2 preferred share and that is a couple years down the line, after who knows how many shares are released.

Question, how many shares need to be issued at .01-.05 to fully fund a 3 phase clinical trial for one pipeline drug?

I think you guys are really off base at this point.If Lilly is on board wouldnt it be cheaper for them to buy RGBP ? Shareholders get paid off.At that point a lawsuit might be smart.Preferred shares may get $100 a share,those that gave themselves millions prior to a sale would be liable.For Lilly to finalize the deal they would want any litigation resolved